Linked Biomarkers Inc.

Linked Biomarkers Inc. (LBI) is an innovative diagnostics company which aims to provide kits for early cancer detection and monitoring of disease progression or remission. Its technology utilises an enhanced and sensitive method for detecting multiple biomarkers in one sample, a vast improvement over existing procedures. The use of biomarkers expressed almost exclusively in tumours and not in normal tissues combined with improved detection signals will decrease false positive and false negative diagnosis. LBI aims to market its products here in the UK, the United States and the rest of the world.